A citation-based method for searching scientific literature

Mohamed Hassan Elnaem, Noha O Mansour, Abdulrahman Fata Nahas, Mohamed A Baraka, Ramadan Elkalmi, Ejaz Cheema. Int J Gen Med 2020
Times Cited: 2







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.
Pantelis Sarafidis, Charles J Ferro, Enrique Morales, Alberto Ortiz, Jolanta Malyszko, Radovan Hojs, Khaled Khazim, Robert Ekart, Jose Valdivielso, Denis Fouque,[...]. Nephrol Dial Transplant 2019
79
100

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
100

Effectiveness and safety of metformin in 51 675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register.
Nils Ekström, Linus Schiöler, Ann-Marie Svensson, Katarina Eeg-Olofsson, Junmei Miao Jonasson, Björn Zethelius, Jan Cederholm, Björn Eliasson, Soffia Gudbjörnsdottir. BMJ Open 2012
151
50

Estimated glomerular filtration rate progression in UK primary care patients with type 2 diabetes and diabetic kidney disease: a retrospective cohort study.
J Cid Ruzafa, R Paczkowski, K S Boye, G L Di Tanna, M J Sheetz, R Donaldson, M D Breyer, D Neasham, J R Voelker. Int J Clin Pract 2015
10
50


Oral glucose lowering drugs in type 2 diabetic patients with chronic kidney disease.
Cláudia Nogueira, Selma B Souto, Eduardo Vinha, Daniel C Braga, Davide Carvalho. Hormones (Athens) 2013
13
50

Carbohydrate metabolism in uremia.
E S Horton, C Johnson, H E Lebovitz. Ann Intern Med 1968
210
50

Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64).
Amanda I Adler, Richard J Stevens, Sue E Manley, Rudy W Bilous, Carole A Cull, Rury R Holman. Kidney Int 2003
50

Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study.
Hiddo J L Heerspink, Avraham Karasik, Marcus Thuresson, Cheli Melzer-Cohen, Gabriel Chodick, Kamlesh Khunti, John P H Wilding, Luis Alberto Garcia Rodriguez, Lucia Cea-Soriano, Shun Kohsaka,[...]. Lancet Diabetes Endocrinol 2020
92
50

Liraglutide and Renal Outcomes in Type 2 Diabetes.
Johannes F E Mann, David D Ørsted, Kirstine Brown-Frandsen, Steven P Marso, Neil R Poulter, Søren Rasmussen, Karen Tornøe, Bernard Zinman, John B Buse. N Engl J Med 2017
486
50


2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.
Giuseppe Mancia, Guy De Backer, Anna Dominiczak, Renata Cifkova, Robert Fagard, Giuseppe Germano, Guido Grassi, Anthony M Heagerty, Sverre E Kjeldsen, Stephane Laurent,[...]. J Hypertens 2007
50



A Greek registry of current type 2 diabetes management, aiming to determine core clinical approaches, patterns and strategies.
Stavros Liatis, Styliani Iraklianou, Kyriakos Kazakos, George Mastorakos, Kostas Milios, Zadalla Mouslech, Marina Noutsou, Emmanouil Pagkalos, Christos Sampanis. BMC Endocr Disord 2019
5
50

Healthy lifestyle and risk of kidney disease progression, atherosclerotic events, and death in CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.
Ana C Ricardo, Cheryl A Anderson, Wei Yang, Xiaoming Zhang, Michael J Fischer, Laura M Dember, Jeffrey C Fink, Anne Frydrych, Nancy G Jensvold, Eva Lustigova,[...]. Am J Kidney Dis 2015
87
50

Effects of intensive blood-pressure control in type 2 diabetes mellitus.
William C Cushman, Gregory W Evans, Robert P Byington, David C Goff, Richard H Grimm, Jeffrey A Cutler, Denise G Simons-Morton, Jan N Basile, Marshall A Corson, Jeffrey L Probstfield,[...]. N Engl J Med 2010
50

Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.
Shelley R Salpeter, Elizabeth Greyber, Gary A Pasternak, Edwin E Salpeter. Cochrane Database Syst Rev 2010
291
50

The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010.
Sarah Stark Casagrande, Judith E Fradkin, Sharon H Saydah, Keith F Rust, Catherine C Cowie. Diabetes Care 2013
511
50

Glucose lowering therapeutic strategies for type 2 diabetic patients with chronic kidney disease in primary care setting in france: a cross-sectional study.
N Grandfils, B Detournay, C Attali, D Joly, D Simon, B Vergès, M Toussi, Y Briand, O Delaitre. Int J Endocrinol 2013
11
50

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).
Paul A James, Suzanne Oparil, Barry L Carter, William C Cushman, Cheryl Dennison-Himmelfarb, Joel Handler, Daniel T Lackland, Michael L LeFevre, Thomas D MacKenzie, Olugbenga Ogedegbe,[...]. JAMA 2014
50

Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
Alfred K Cheung, Tara I Chang, William C Cushman, Susan L Furth, Joachim H Ix, Roberto Pecoits-Filho, Vlado Perkovic, Mark J Sarnak, Sheldon W Tobe, Charles R V Tomson,[...]. Kidney Int 2019
32
50

Management of type 2 diabetes and its prescription drug cost before and during the economic crisis in Greece: an observational study.
Stavros Liatis, Stavroula Papaoikonomou, Asimina Ganotopoulou, Athanasia Papazafiropoulou, Constantinos Dinos, Marios Michail, Apostolos Xilomenos, Andreas Melidonis, Stavros Pappas. BMC Endocr Disord 2014
9
50

Adherence to the National Guidelines for Follow-Up Protocol in Subjects with Type 2 Diabetes Mellitus in Greece: The GLANCE Study.
Nikolaos Papanas, Moses Elisaf, Kalliopi Kotsa, Andreas Melidonis, Stavros Bousboulas, Alexandra Bargiota, Emmanouel Pagkalos, John Doupis, Ioannis Ioannidis, Iakovos Avramidis,[...]. Diabetes Ther 2020
1
100

Renal Protective Effect of DPP-4 Inhibitors in Type 2 Diabetes Mellitus Patients: A Cohort Study.
Young-Gun Kim, JungHyun Byun, Dukyong Yoon, Ja Young Jeon, Seung Jin Han, Dae Jung Kim, Kwan-Woo Lee, Rae Woong Park, Hae Jin Kim. J Diabetes Res 2016
22
50


The pharmacokinetics of pioglitazone in patients with impaired renal function.
Klemens Budde, Hans-Hellmut Neumayer, Lutz Fritsche, Wladyslaw Sulowicz, Tomasz Stompôr, David Eckland. Br J Clin Pharmacol 2003
100
50



Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.
Szu-chi Chen, Chin-Hsiao Tseng. Rev Diabet Stud 2013
46
50

The prevalence of diabetic chronic kidney disease in adult Greek subjects with type 2 diabetes mellitus: A series from hospital-based diabetes clinics.
Ilias N Migdalis, Nikolaos Papanas, Athanasios E Raptis, Ioannis M Ioannidis, Alexios E Sotiropoulos, George D Dimitriadis. Diabetes Res Clin Pract 2020
1
100

Association between glycemic control and adverse outcomes in people with diabetes mellitus and chronic kidney disease: a population-based cohort study.
Sabin Shurraw, Brenda Hemmelgarn, Meng Lin, Sumit R Majumdar, Scott Klarenbach, Braden Manns, Aminu Bello, Matthew James, Tanvir Chowdhury Turin, Marcello Tonelli. Arch Intern Med 2011
164
50

Glucose control and vascular complications in veterans with type 2 diabetes.
William Duckworth, Carlos Abraira, Thomas Moritz, Domenic Reda, Nicholas Emanuele, Peter D Reaven, Franklin J Zieve, Jennifer Marks, Stephen N Davis, Rodney Hayward,[...]. N Engl J Med 2009
50

2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Paul K Whelton, Robert M Carey, Wilbert S Aronow, Donald E Casey, Karen J Collins, Cheryl Dennison Himmelfarb, Sondra M DePalma, Samuel Gidding, Kenneth A Jamerson, Daniel W Jones,[...]. J Am Coll Cardiol 2018
50

Diabetic Kidney Disease and Hypertension: A True Love Story.
Anand Verma, Sony Vyas, Abhishek Agarwal, Shahid Abbas, Devi Prasad Agarwal, Ravindra Kumar. J Clin Diagn Res 2016
4
50


Type 2 diabetes as an inflammatory disease.
Marc Y Donath, Steven E Shoelson. Nat Rev Immunol 2011
50

Update on Diabetic Nephropathy: Core Curriculum 2018.
Kausik Umanath, Julia B Lewis. Am J Kidney Dis 2018
210
50

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.
Helen M Colhoun, D John Betteridge, Paul N Durrington, Graham A Hitman, H Andrew W Neil, Shona J Livingstone, Margaret J Thomason, Michael I Mackness, Valentine Charlton-Menys, John H Fuller. Lancet 2004
50


Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
50

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult.
Todd J Anderson, Jean Grégoire, Glen J Pearson, Arden R Barry, Patrick Couture, Martin Dawes, Gordon A Francis, Jacques Genest, Steven Grover, Milan Gupta,[...]. Can J Cardiol 2016
487
50


Real life treatment of diabetes mellitus type 2 patients: an analysis based on a large sample of 394,828 German patients.
Thomas Wilke, Antje Groth, Andreas Fuchs, Lisa Seitz, Joachim Kienhöfer, Rainer Lundershausen, Ulf Maywald. Diabetes Res Clin Pract 2014
16
50

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
50

The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes.
Diethelm Tschöpe, Markolf Hanefeld, Juris J Meier, Anselm K Gitt, Martin Halle, Peter Bramlage, Petra-Maria Schumm-Draeger. Cardiovasc Diabetol 2013
19
50

Discordance in risk factors for the progression of diabetic retinopathy and diabetic nephropathy in patients with type 2 diabetes mellitus.
Ki-Ho Song, Jee-Sun Jeong, Mee Kyoung Kim, Hyuk-Sang Kwon, Ki-Hyun Baek, Seung-Hyun Ko, Yu-Bae Ahn. J Diabetes Investig 2019
15
50

KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD.
Lesley A Inker, Brad C Astor, Chester H Fox, Tamara Isakova, James P Lash, Carmen A Peralta, Manjula Kurella Tamura, Harold I Feldman. Am J Kidney Dis 2014
717
50

Metformin and other antidiabetic agents in renal failure patients.
Jean-Daniel Lalau, Paul Arnouts, Adnan Sharif, Marc E De Broe. Kidney Int 2015
77
50

Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives.
M Virally, J-F Blicklé, J Girard, S Halimi, D Simon, P-J Guillausseau. Diabetes Metab 2007
69
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.